StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) stock

ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

Estrella Immunopharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Estrella Immunopharma's enterprise value was $21.42M on Nov 11, 2026, against $73.08M a year earlier. Over the last 5 years it ranged from $1.79M to $84.43M, with a median of $25.12M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$21.42M-59.5%
2025Dec 31, 2025$52.95M+33.1%
2024Dec 31, 2024$39.77M+134.8%
2023Dec 29, 2023$16.94M+19.9%
2022Dec 30, 2022$14.13M+6.3%
2021Dec 31, 2021$13.30M–

More Estrella Immunopharma figures

See a number that looks wrong?